We are live on ! Find out more
DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale Portfolio holdings

AUM $59.2B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+8.43%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$34.3B
AUM Growth
+$4.15B
Cap. Flow
+$1.92B
Cap. Flow %
5.6%
Top 10 Hldgs %
23.44%
Holding
1,439
New
97
Increased
478
Reduced
443
Closed
54

Top Buys

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$200M
2
AMZN icon
Amazon
AMZN
+$126M
3
DB icon
Deutsche Bank
DB
+$109M
4
ISRG icon
Intuitive Surgical
ISRG
+$92.2M
5
WFC icon
Wells Fargo
WFC
+$83.3M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$126M
2
ABT icon
Abbott
ABT
+$79.1M
3
VFC icon
VF Corp
VFC
+$49M
4
JPM icon
JPMorgan Chase
JPM
+$48.5M
5
BNTX icon
BioNTech
BNTX
+$46.9M

Sector Composition

Rank Sector Weight
1 Technology 25.97%
2 Healthcare 15.46%
3 Financials 11.88%
4 Communication Services 9.65%
5 Consumer Discretionary 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PAAS icon
1051
Pan American Silver
PAAS
$21.8B
$559K ﹤0.01%
19,721
-99,170
-83% -$3.2M
ALXO icon
1052
ALX Oncology
ALXO
$285M
$555K ﹤0.01%
10,500
– –
FLG
1053
Flagstar Bank National Association
FLG
$5.84B
$553K ﹤0.01%
16,906
– –
NBP
1054
NovaBridge Biosciences American Depositary Shares
NBP
$205M
$552K ﹤0.01%
6,904
+2,104
+44% +$139K
SCPL
1055
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$548K ﹤0.01%
32,000
– –
QNCX icon
1056
Quince Therapeutics
QNCX
$30M
$544K ﹤0.01%
50
– –
LGND icon
1057
Ligand Pharmaceuticals
LGND
$6.42B
$539K ﹤0.01%
6,476
– –
ATEN icon
1058
A10 Networks
ATEN
$2.06B
$532K ﹤0.01%
47,750
– –
MNDT
1059
DELISTED
Mandiant, Inc. Common Stock
MNDT
$525K ﹤0.01%
25,850
– –
MIME
1060
DELISTED
Mimecast Limited
MIME
$524K ﹤0.01%
9,825
– –
CSTL icon
1061
Castle Biosciences
CSTL
$988M
$523K ﹤0.01%
7,000
– –
FLS icon
1062
Flowserve
FLS
$10.1B
$520K ﹤0.01%
13,207
– –
SITM icon
1063
SiTime
SITM
$20.7B
$515K ﹤0.01%
+4,000
New +$409K
CYTK icon
1064
Cytokinetics
CYTK
$10.5B
$513K ﹤0.01%
24,600
– –
AU icon
1065
AngloGold Ashanti
AU
$49.2B
$512K ﹤0.01%
28,100
-8,500
-23% -$187K
CHT icon
1066
Chunghwa Telecom
CHT
$32.8B
$511K ﹤0.01%
+12,815
New +$521K
CG icon
1067
Carlyle Group
CG
$17.2B
$506K ﹤0.01%
10,993
+2,078
+23% +$88.4K
RNR icon
1068
RenaissanceRe
RNR
$13.2B
$503K ﹤0.01%
3,396
-1,252
-27% -$199K
FWONK icon
1069
Liberty Media Series C
FWONK
$25.8B
$500K ﹤0.01%
10,431
-2,250
-18% -$98.8K
AMTI
1070
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$489K ﹤0.01%
11,000
– –
INO icon
1071
Inovio Pharmaceuticals
INO
$76.1M
$488K ﹤0.01%
4,500
– –
DOYU
1072
DouYu International Holdings
DOYU
$134M
$486K ﹤0.01%
6,829
+23
+0.3% +$1.98K
ERIE icon
1073
Erie Indemnity
ERIE
$13.2B
$485K ﹤0.01%
2,542
+150
+6% +$30.9K
INVA icon
1074
Innoviva
INVA
$1.49B
$485K ﹤0.01%
37,200
– –
IRT icon
1075
Independence Realty Trust
IRT
$3.94B
$485K ﹤0.01%
+27,286
New +$463K
41 42
43
44 45

Similar funds

Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Aviva
Aviva London, United Kingdom $59.6B AUM 28.44% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

DekaBank Deutsche Girozentrale's Q2 2021 Portfolio in Review

As of Q2 2021, DekaBank Deutsche Girozentrale held 1,439 positions worth $34.3B, up 14% from $30.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

DekaBank Deutsche Girozentrale deployed $1.92B of net new capital in Q2 2021, opening 97 new positions and adding to 478 existing holdings. Its largest new stake was Stellantis: 10,647,151 shares worth $207M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Broadcom, an estimated $126M trimmed.

  • DekaBank Deutsche Girozentrale's largest Q2 2021 buy was Stellantis: 10,647,151 shares worth $207M.
  • DekaBank Deutsche Girozentrale added most to Amazon in Q2 2021, an estimated $126M increase.
  • DekaBank Deutsche Girozentrale's biggest Q2 2021 reduction was Broadcom, cutting an estimated $126M.
  • DekaBank Deutsche Girozentrale fully exited CureVac in Q2 2021, selling an estimated $6.93M.
  • DekaBank Deutsche Girozentrale's ten largest holdings make up 23% of its $34.3B portfolio in Q2 2021.
  • DekaBank Deutsche Girozentrale opened 97 new positions and closed 54 in Q2 2021.
  • DekaBank Deutsche Girozentrale's portfolio value rose 14% quarter-over-quarter to $34.3B.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2021, filed 5 Aug 2021.